Pharmaceutical Industry Reports Rivaroxaban market Haga clic para leer
  • Comentarios

Pharmaceutical Industry Reports

Rivaroxaban market

Publicado el en “Salud y Estado Físico, Ciencia”, Idioma — English. 8 páginas.
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Más
Mostrar Etiquetas

Otras publicaciones de “Pharmaceutical Industry Reports”

Ver todas las publicaciones